Email this article Evaluating the effectiveness of Tranexam by transurethral resection of the prostate in patients with BPH
- Authors: Goloshchapov Y.T.1, Lukichev G.B.2, Nevirovich Y.S.3, Kuzmin I.V.1, Ignashov Y.A.2
-
Affiliations:
- Department of Urology. St.-Petersburg State I. P. Pavlov Medical University
- St.-Petersburg State I. P. Pavlov Medical University
- St.-Petersburg State I. P. Pavlov Medical University.
- Issue: Vol 2, No 4 (2012)
- Pages: 16-19
- Section: Articles
- URL: https://journals.rcsi.science/uroved/article/view/2516
- DOI: https://doi.org/10.17816/uroved2416-19
- ID: 2516
Cite item
Full Text
Abstract
214 patients with BPH who underwent transurethral resection of the prostate were observed. Patients in Group 1 (n = 121) was administered Tranexam that containins fibrinolysis inactivator tranexamic acid. Tranexam administered orally once before surgery at a dose of 1 g per day and at the day of operation intravenously 15 mg/kg body weight every 8 hours.The control group 2 (n = 93) did not take Tranexam. There were found that patients in Group 1 compared to the 2nd group had significantly less time of postoperative hematuria (4.6 ± 0.3 h and 18.6 ± 1.3 h, respectively). The value of intraoperative blood loss in patients in the two groups did not differ
Full Text
##article.viewOnOriginalSite##About the authors
Yevgeniy Tikhonovich Goloshchapov
Department of Urology. St.-Petersburg State I. P. Pavlov Medical University
Email: Goloshapov@mail.ru
doctor of medical science, professor
Georgiy Borisovich Lukichev
St.-Petersburg State I. P. Pavlov Medical University
Email: dr_lu@inbox.ru
urologist
Yevgeniy Stanislavovich Nevirovich
St.-Petersburg State I. P. Pavlov Medical University.candidate of medical science
Igor Valentinovich Kuzmin
Department of Urology. St.-Petersburg State I. P. Pavlov Medical University
Email: kuzminigor@mail.ru
doctor of medical science, professor
Yuriy Anatolyevich Ignashov
St.-Petersburg State I. P. Pavlov Medical Universityurologist
References
- Васильев С. А., Виноградов В. Л., Гемджян Э. Г. Транексам — антифибринолитический гемостатик // Тромбоз, гемостаз и реология. 2008. № 1. C. 28–34.
- Гориловский Л. М. Эпидемиология, факторы риска развития и биологическое течение доброкачественной гиперплазии предстательной железы / В: Лопаткин Н. А, ред. Доброкачественная гиперплазия предстательной железы. М., 1999. C.12–20.
- Голайко В. Ю., Кореньков Д. Г., Голощапов Е. Т. Профилактика кровопотери при аденомэктомии у больных доброкачественной гиперплазией предстательной железы старческого возраста // Нефрология. 2007. Т. 11, № 1. С. 113–116.
- Голощапов Е. Т., Лукичёв Г. Б. Особенности гемостаза при трансуретральной резекции предстательной железы с применением ингибитора фибринолиза // Урологические ведомости. 2011. Т. 1, № 1. С. 34–39.
- Ткачук И. Н. Осложнения трансуретральной резекции простаты у больных доброкачественной гиперплазией предстательной железы и пути их профилактики. Автореф. дисс.. канд. мед. наук. СПб., 2011. 17 с.
- Berry S. J., Coffey D. S., Walsh P. C., Ewing L. L. The development of human benign prostatic hyperplasia with age // J. Urol. 1984. Vol. 132. P. 474–479.
- Cap A. P., Baer D. G., Orman J. A. et al. Tranexamic acid for trauma patients: a critical review of the literature // J. Trauma. 2011. Vol. 71, N 1 Suppl. S9–14.
- Grottke O. Coagulation management // Curr. Opin. Crit. Care. 2012. Vol. 18, N 6. P.641–646.
- Hartung R., Mauermayer W., Beck F., Karcher G. The controlled TUR: a new method for the measurement of intraoperative blood-loss during TUR // Urologe A. 1976. Vol. 15, N 5. P.254–257.
- Ipema H. J., Tanzi M. G. Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures//Ann Pharmacother. 2012. Vol. 46, N 1. P. 97–107.
- Kobayashi T., Sugiura J. The effect of a new potent antifibrinolytic agent, tranexamic acid // J. Jpn. Obstet. Gynecol. Soc. 1966. Vol. 13, N 3. P. 158–167.
- Pusateri A.E, Weiskopf R.B, Bebarta V. et al. Tranexamic Acid and Trauma: Current Status and Knowledge Gaps With Recommended Research Priorities // Shock. 2013. Vol. 39, N 2. P. 121–126.
- Seto A. H., Dunlap D. S. Tranexamic acid in oncology // Ann Pharmacother. 1996. Vol. 30, N 7–8. P. 868–870.
- Wellington K., Wagstaff A. J. Tranexamic acid: a review of its use in the management of menorrhagia // Drugs. 2003. Vol. 63, N 13. P. 1417–1433.
